A pharmaceutical research organization operates a platform where external laboratories submit clinical trial data files. To meet regulatory requirements, the security team must implement a mechanism ensuring that a submitting laboratory cannot later deny having submitted a specific file. Which of the following mechanisms best provides this non-repudiation capability?
- Asymmetric digital signatures generated using the submitting laboratory's private keyCevap
- BSHA-256 cryptographic hashing applied to each file prior to transmission
- CHash-based Message Authentication Codes (HMAC) calculated using a pre-shared symmetric key
- DRole-based access control (RBAC) configured to restrict storage bucket permissions
Cevap
Asymmetric digital signatures generated using the submitting laboratory's private key
Asymmetric digital signatures provide non-repudiation because they pair a unique private key (known only to the sender) with a public key. Signing a hash of the file with the private key cryptographically binds the sender's identity to the file payload.
Adım Adım Çözüm
Anahtar Kavram
Non-Repudiation vs. Integrity and Symmetric Authentication